Initiator Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 7.2%.

Top 16 shareholders own 47.07% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
17.9%	Linc AB	10,091,219	SEK 65.1m	0%	2.97%
6.42%	Adrigo Asset Management AB	3,611,949	SEK 23.3m	0%	45.6%
5.49%	Avanza Fonder AB	3,090,593	SEK 19.9m	0%	0.02%
4.04%	Claus Olesen	2,274,876	SEK 14.7m	0%	no data
3.32%	BNY Asset Management	1,865,645	SEK 12.0m	0%	no data
1.65%	Nordnet AB (publ), Asset Management Arm	927,295	SEK 6.0m	0%	0.08%
1.54%	UBS Asset Management AG	866,805	SEK 5.6m	0%	no data
1.35%	Mats Thorén	756,895	SEK 4.9m	0%	no data
1.34%	Mikael Thomsen	753,056	SEK 4.9m	0%	no data
1.34%	Danpet AB	753,056	SEK 4.9m	0%	no data
1.16%	Ulf Simonsen	652,802	SEK 4.2m	0%	no data
0.71%	Annette Colin	396,948	SEK 2.6m	0%	no data
0.48%	Gunnar Magnus Severus Persson	267,186	SEK 1.7m	0%	no data
0.25%	Henrik Moltke	139,106	SEK 897.2k	0%	no data
0.034%	Gunilla Ekstrom	19,000	SEK 122.5k	0%	no data
0.0094%	FCG Fonder AB	5,294	SEK 34.1k	0%	no data